Response: Re: Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

John P A Ioannidis; Davide Mauri; Nikolaos P. Polyzos; Nicholas Pavlidis

doi:10.1093/jnci/djk023

Back

Response: Re: Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Article 2007 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Davide Mauri, Nicholas Pavlidis, Nikolaos P. Polyzos, John P A Ioannidis

Article2006

Survival benefit with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: Meta-analysis

Davide Mauri, Nikolaos P. Polyzos, John P A Ioannidis, Eleni Timotheadou, Nicholas Pavlidis

Article2005

RESPONSE: Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

Davide Mauri, Nicholas Pavlidis, John P A Ioannidis

Article2015

Aromatase inhibitors in male breast cancer: a pooled analysis

Flora Zagouri, Theodoros Ν. Sergentanis, Hatem A. Azim, Dimosthenis Chrysikos, Meletios A Dimopoulos, Θεοδώρα Ψαλτοπούλου

Article1999

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies

Eva Negri, Αναστασία Τζώνου, Valerie Beral, Παγώνα Λάγιου, Dimitrios Trichopoulos, Fabio Parazzini, Silvia Franceschi, Margareth Booth, Carlo La Vecchia